TerminatedPhase 2NCT00003852
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- UNICANCER
- Principal Investigator
- Pierre Biron, MDCentre Leon Berard
- Intervention
- filgrastim(biological)
- Enrollment
- 45 enrolled
- Eligibility
- 15-120 years · All sexes
- Timeline
- 1998 – 2000
Study locations (18)
- Centre Paul Papin, Angers, France
- CHR de Besancon - Hopital Jean Minjoz, Besançon, France
- Institut Bergonie, Bordeaux, France
- Centre Regional Francois Baclesse, Caen, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, France
- CHR de Grenoble - La Tronche, Grenoble, France
- Clinique Saint Michel, La Rochelle, France
- Centre Leon Berard, Lyon, France
- Institut J. Paoli and I. Calmettes, Marseille, France
- Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France
- Centre Antoine Lacassagne, Nice, France
- Hopital d'Instruction des Armees du Val de Grace, Paris, France
- Institut Jean Godinot, Reims, France
- Centre Henri Becquerel, Rouen, France
- +3 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003852 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology